Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (n-methyl-(11c))vorozole
2. 6-((4-chlorophenyl)-(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzotriazole
3. R 76713
4. R 83839
5. R 83842
6. R-76713
7. R-83839
8. R-83842
9. Vorozole
10. Vorozole, (+)-isomer
1. Vorozole
2. 129731-10-8
3. R-83842
4. 1e2s9yxv2a
5. R 83842
6. 6-[(s)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
7. Vorozolum
8. Vorozol
9. 1h-benzotriazole, 6-((4-chlorophenyl)-1h-1,2,4-triazol-1-ylmethyl)-1-methyl-, (s)-
10. (s)-6-((4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzo[d][1,2,3]triazole
11. Vorozol [inn-spanish]
12. Vorozolum [inn-latin]
13. Unii-1e2s9yxv2a
14. Vorozole [usan:inn:ban]
15. Ccris 7482
16. Rivizor (tn)
17. Vorozole [usan]
18. Vorozole (usan/inn)
19. Vorozole [inn]
20. Vorozole [mi]
21. (s)-vorozole
22. Vorozole [mart.]
23. Vorozole [who-dd]
24. Schembl4554
25. Chembl224060
26. Dtxsid20156230
27. Chebi:135387
28. Bcp04202
29. Zinc3791538
30. Bdbm50378780
31. Db13767
32. (+)-(s)-6-(p-chloro-alpha-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole
33. R76713
34. Hy-19599
35. Bcp0726000088
36. Cs-0015881
37. D03786
38. R-83942
39. Q7941876
40. (+)-(s)-6-(p-chloro-a-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole
41. (+)-6-[(4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl]-1-methyl-1h- Benzotriazole
42. (s)-6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
43. 1-methyl-6-[(s)-alpha-(1h-1,2,4-triazol-1-yl)-4-chlorobenzyl]-1h-benzotriazole
| Molecular Weight | 324.77 g/mol |
|---|---|
| Molecular Formula | C16H13ClN6 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 324.0890221 g/mol |
| Monoisotopic Mass | 324.0890221 g/mol |
| Topological Polar Surface Area | 61.4 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 402 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Aromatase Inhibitors
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. (See all compounds classified as Aromatase Inhibitors.)
L - Antineoplastic and immunomodulating agents
L02 - Endocrine therapy
L02B - Hormone antagonists and related agents
L02BG - Aromatase inhibitors
L02BG05 - Vorozole
ABOUT THIS PAGE
40
PharmaCompass offers a list of Vorozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vorozole manufacturer or Vorozole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vorozole manufacturer or Vorozole supplier.
A Vorozol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vorozol, including repackagers and relabelers. The FDA regulates Vorozol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vorozol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vorozol supplier is an individual or a company that provides Vorozol active pharmaceutical ingredient (API) or Vorozol finished formulations upon request. The Vorozol suppliers may include Vorozol API manufacturers, exporters, distributors and traders.
click here to find a list of Vorozol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Vorozol DMF (Drug Master File) is a document detailing the whole manufacturing process of Vorozol active pharmaceutical ingredient (API) in detail. Different forms of Vorozol DMFs exist exist since differing nations have different regulations, such as Vorozol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vorozol DMF submitted to regulatory agencies in the US is known as a USDMF. Vorozol USDMF includes data on Vorozol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vorozol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vorozol suppliers with USDMF on PharmaCompass.
Vorozol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vorozol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vorozol GMP manufacturer or Vorozol GMP API supplier for your needs.
A Vorozol CoA (Certificate of Analysis) is a formal document that attests to Vorozol's compliance with Vorozol specifications and serves as a tool for batch-level quality control.
Vorozol CoA mostly includes findings from lab analyses of a specific batch. For each Vorozol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vorozol may be tested according to a variety of international standards, such as European Pharmacopoeia (Vorozol EP), Vorozol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vorozol USP).
